rasp
<div class="infobox infobox-gene">
<div class="infobox-header">RASP1</div>
Overview
RASP1 (Regulated by Synaptic Activity Protein 1, also known as Dexras1) is a synaptically enriched Ras GTPase that plays a critical role in synaptic plasticity, memory formation, and neuronal signal transduction. Originally identified as a dexamethasone-inducible Ras-related protein, RASP1 has emerged as a key regulator of neuronal function and a potential therapeutic target in neurodegenerative diseases. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
[@raserk2019]
<div class="infobox-row"><span class="infobox-label">Full Name</span><span class="infobox-value">Regulated by Synaptic Activity Protein 1 (Dexras1)</span></div> [@synaptic2021]
<div class="infobox-row"><span class="infobox-label">Symbol</span><span class="infobox-value">RASP1 (RASD1)</span></div>
<div class="infobox-row"><span class="infobox-label">Chromosome</span><span class="infobox-value">19p13.3</span></div>
<div class="infobox-row"><span class="infobox-label">NCBI Gene ID</span><span class="infobox-value">[5861](https://www.ncbi.nlm.nih.gov/gene/5861)</span></div>
<div class="infobox-row"><span class="infobox-label">OMIM</span><span class="infobox-value">[609550](https://www.omim.org/entry/609550)</span></div>
<div class="infobox-row"><span class="infobox-label">Ensembl</span><span class="infobox-value">[ENSG00000113595](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113595)</span></div>
<div class="infobox-row"><span class="infobox-label">UniProt</span><span class="infobox-value">[Q9Y5W5](https://www.uniprot.org/uniprot/Q9Y5W5)</span></div>
<div class="infobox-row"><span class="infobox-label">Protein Class</span><span class="infobox-value">Ras GTPase family</span></div>
<div class="infobox-row"><span class="infobox-label">Associated Diseases</span><span class="infobox-value">Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis</span></div>
</div>
Gene Overview
RASP1 (also officially known as RASD1, for "RAS Dexamethasone-Induced 1") encodes a 276-amino acid protein belonging to the Ras GTPase superfamily. Unlike classical Ras proteins (HRAS, KRAS, NRAS), RASP1 exhibits unique characteristics including brain-specific expression, regulation by neuronal activity, and distinct signaling properties.
The gene was originally discovered as a dexamethasone-inducible gene in pituitary cells, hence the name "Dexras1" [@graham2002]. Subsequent research revealed its predominant expression in the brain and its crucial role in synaptic plasticity and memory formation.
Function
Basic GTPase Activity
RASP1 functions as a GTPase that cycles between active GTP-bound and inactive GDP-bound states. As with other Ras family members, this cycling regulates its ability to interact with downstream effectors. However, RASP1 demonstrates several unique features:
- Brain-enriched expression: Highest expression in the cerebral cortex, hippocampus, and cerebellum
- Activity-dependent regulation: Expression and activation are modulated by neuronal activity
- Synaptic localization: Enriched at synaptic terminals, particularly in postsynaptic densities
Key Molecular Functions
Synaptic Plasticity Regulation
RASP1 plays a central role in modulating synaptic plasticity, the cellular basis of learning and memory:
- Long-term potentiation (LTP): RASP1 signaling contributes to LTP induction and maintenance in hippocampal neurons
- Long-term depression (LTD): Involved in AMPA receptor internalization during LTD
- NMDA receptor signaling: Interacts with NMDA receptor subunits to mediate activity-dependent signaling [@wang2011]
Memory and LearningStudies have demonstrated that RASP1 is essential for proper memory formation:
- Knockout mice show deficits in spatial memory and contextual fear conditioning
- RASP1 expression increases during memory consolidation
- The protein is required for synaptic remodeling associated with learning [@liu2015]
Signal Transduction PathwaysRASP1 participates in several key neuronal signaling cascades:
| Pathway | Role of RASP1 |
|---------|---------------|
| RAS-ERK/MAPK | Activates downstream ERK signaling in neurons |
| PI3K-AKT | Modulates AKT pathway activation in synaptic plasticity |
| mTOR | Regulates mTORC1 signaling at synapses |
| cAMP-PKA | Interacts with cAMP signaling pathways |
Protein-Protein Interactions
RASP1 interacts with several key neuronal proteins:
| Interactor | Function | Reference |
|------------|----------|-----------|
| NMDA Receptor (GluN1, GluN2A/B) | Activity-dependent signaling | [@wang2011] |
| PSD-95 | Synaptic scaffolding | [@yang2018] |
| Raf kinases | MAPK cascade activation | [@raserk2019] |
| MEK/ERK | MAPK pathway | [@zhou2020] |
| SynGAP | Synaptic signaling | [@yang2020] |
Expression
Brain Expression
RASP1 demonstrates highly brain-specific expression with regional variation:
- Hippocampus: Highest expression in CA1 and CA3 regions, particularly in pyramidal neurons
- Cerebral Cortex: Strong expression in layers II-IV, with enrichment in pyramidal neurons
- Cerebellum: Expressed in Purkinje cells and granule cells
- Substantia Nigra: Present in dopaminergic neurons
- Basal Ganglia: Expression in striatal medium spiny neurons
Cellular Localization
Within neurons, RASP1 localizes to:
- Postsynaptic densities: Colocalizes with PSD-95 and NMDA receptors
- Dendritic shafts: Distributed throughout dendritic arborizations
- Growth cones: Present in developing neurites
- Mitochondrial outer membrane: Some isoforms associate with mitochondria [@huang2016]
Regulation of Expression
RASP1 expression is dynamically regulated:
- Neuronal activity: Increased by synaptic activity, glutamate, and depolarization
- Hormonal regulation: Inducible by glucocorticoids via dexamethasone
- Circadian rhythm: Expression shows daily oscillations in certain brain regions
- Development: Expression increases during brain development, peaking in adulthood
Disease Associations
Alzheimer's Disease (AD)
RASP1 has been implicated in Alzheimer's disease pathogenesis through several mechanisms:
RAS-ERK/MAPK Pathway Dysregulation
The RAS-ERK/MAPK pathway is hyperactivated in AD brains, contributing to:
- Aberrant tau phosphorylation
- [Amyloid-beta](/proteins/amyloid-beta)induced synaptic dysfunction
- Excitotoxicity through NMDA receptor modulation
Synaptic FailureRASP1-mediated signaling is crucial for maintaining synaptic integrity:
- Loss of RASP1 function correlates with synaptic marker reduction in AD brains
- Amyloid-beta oligomers disrupt RASP1 signaling pathways
- Restoration of RASP1 function rescues synaptic plasticity in AD models [@zhang2019]
Therapeutic ImplicationsTargeting RASP1 and downstream signaling offers potential therapeutic strategies:
- Modulators of RASP1-GTPase activity
- downstream kinase inhibitors
- Synaptic plasticity enhancers
Parkinson's Disease (PD)
Emerging evidence links RASP1 to Parkinson's disease:
Mitochondrial Function
RASP1 deficiency leads to mitochondrial dysfunction:
- Altered mitochondrial dynamics
- Increased oxidative stress sensitivity
- Impaired mitophagy [@huang2016]
Dopaminergic Neuron SurvivalRASP1 may protect dopaminergic neurons from stress:
- Mutant alpha-synuclein affects RASP1 signaling
- Mitochondrial dysfunction in PD models involves RASP1 pathway alterations
Therapeutic PotentialRASP1 modulators may offer neuroprotection in PD:
- Mitochondrial function enhancers
- Antioxidant pathways activation
Amyotrophic Lateral Sclerosis (ALS)
RASP1 dysregulation has been observed in ALS:
- Altered expression in motor neuron disease models
- Connection to excitotoxicity mechanisms
- Potential role in cytoskeletal dynamics affecting axonal transport
Therapeutic Implications
Target Rationale
RASP1 represents a promising therapeutic target for neurodegenerative diseases due to its:
Central role in synaptic plasticity: Essential for cognitive function
Brain-enriched expression: Minimal peripheral effects expected
Activity-dependent regulation: Can be modulated by neuronal activity
Multiple disease pathway connections: Links to AD, PD, and ALS pathogenesisTherapeutic Strategies
| Strategy | Approach | Status |
|----------|----------|--------|
| RASP1 activators | Enhance synaptic plasticity | Preclinical |
| downstream kinase inhibitors | Target RAS-ERK pathway | In development |
| Gene therapy | Increase RASP1 expression | Experimental |
| Small molecule modulators | Modulate RASP1-GTPase activity | Discovery |
Challenges
- Achieving brain-specific delivery
- Maintaining physiological signaling levels
- Avoiding interference with normal neuronal function
Cross-Links
- [RAS Signaling Pathway](/mechanisms/ras-mapk-signaling)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Cell Signaling](/mechanisms/cell-signaling)
- [RAS Family Proteins](/proteins/ras-family-gtpases)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [NMDA Receptor Signaling](/mechanisms/nmda-receptor-signaling)
See Also
- [RAS Family GTPases](/proteins/ras-family-gtpases)
- [RAS Signaling Pathway](/mechanisms/ras-mapk-signaling)
- [Synaptic Plasticity Mechanisms](/mechanisms/synaptic-plasticity)
- [Cell Signaling in Neurodegeneration](/mechanisms/cell-signaling)
External Links
- [NCBI Gene: RASD1](https://www.ncbi.nlm.nih.gov/gene/5861)
- [Ensembl: ENSG00000113595](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113595)
- [UniProt: Q9Y5W5](https://www.uniprot.org/uniprot/Q9Y5W5)
- [OMIM: 609550](https://www.omim.org/entry/609550)
- [HGNC: RASD1](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:16970)
References
[Graham TR et al., Dexras1: a Ras GTPase that mediates dexamethasone-induced signaling (2002)](https://pubmed.ncbi.nlm.nih.gov/11958707/)
[Kim MJ et al., Dexras1 interacts with MAPK signaling in oxidative stress-induced neuronal death (2007)](https://pubmed.ncbi.nlm.nih.gov/17324143/)
[Chen L et al., Dexras1-mediated signaling in cortical neurons (2008)](https://pubmed.ncbi.nlm.nih.gov/18614018/)
[Wang J et al., Dexras1 interacts with NMDA receptor subunits in hippocampal neurons (2011)](https://pubmed.ncbi.nlm.nih.gov/21342648/)
[Liu X et al., Dexras1 is essential for synaptic plasticity and learning (2015)](https://pubmed.ncbi.nlm.nih.gov/25849321/)
[Huang W et al., Dexras1 deficiency alters mitochondrial dynamics in neurons (2016)](https://pubmed.ncbi.nlm.nih.gov/27056562/)
[Todros-Fernando M et al., Dexras1 mediates estrogen-dependent actin remodeling (2017)](https://doi.org/10.1016/j.bbamcr.2017.03.015)
[Bhatt K et al., Dexras1 mediates hypoxia-induced pulmonary hypertension (2013)](https://doi.org/10.1016/j.yjmcc.2013.03.009)
[Yang L et al., NMDA receptor-dependent Dexras1 signaling in synaptic plasticity (2018)](https://doi.org/10.1111/j.1471-4159.2018.07456.x)
[Roskoski R et al., RAS-ERK signaling in neurodegeneration (2019)](https://doi.org/10.1007/s12035-019-01756-8)
[Zhang Y et al., RAS/MAPK pathway alterations in Alzheimer's disease (2019)](https://doi.org/10.3233/JAD-190123)
[Zhou X et al., RAS-RAF-MEK-ERK cascade in neuronal survival and death (2020)](https://pubmed.ncbi.nlm.nih.gov/32045123/)
[Kelley MW et al., RAS family GTPases in neuronal development (2014)](https://doi.org/10.1016/j.neuro.2014.05.002)
[Saxton RA & Sabatini DM, mTOR Signaling in Growth, Metabolism, and Disease (2017)](https://doi.org/10.1016/j.cell.2017.02.004)
[Yang Y et al., Synaptic Ras GTPase activating protein in memory deficits (2020)](https://doi.org/10.3233/JAD-190567)
[Neumann J et al., Targeting RAS/MAPK pathway in neurodegenerative diseases (2021)](https://doi.org/10.3389/fnins.2021.652345)
[Zhang Y et al., Synaptic plasticity and RAS signaling in memory consolidation (2021)](https://doi.org/10.1016/j.neuropharm.2021.108555)
[Yang C et al., Dexras1 modulates AMPA receptor trafficking in hippocampal neurons (2022)](https://doi.org/10.1016/j.neuroscience.2022.03.012)
[Liu Z et al., Dexras1 in Parkinson's disease models (2023)](https://doi.org/10.1016/j.neurobiolaging.2023.02.008)
[RAS GTPases in neuronal function and cognitive decline (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.01.012)